Metabolic Syndrome Metabolic syndrome is a complex cluster of interrelated metabolic disorders that significantly increase the risk of cardiovascular disease, type 2 diabetes mellitus, and stroke. It is characterized by a combination of central obesity, insulin resistance, hypertension, dyslipidemia (elevated triglycerides and reduced HDL cholesterol), and impaired glucose tolerance. The condition is driven by genetic predisposition, sedentary lifestyle, unhealthy dietary patterns, and chronic low-grade inflammation. Metabolic syndrome has become a major global public health concern due to its strong association with obesity, aging populations , and urbanization. Early diagnosis, lifestyle modification, and targeted medical interventions are critical for reducing long-term morbidity and mortality. Metabolic syndrome, insulin resistance, obesity, dyslipidemia, hypertension, type 2 diabetes, cardiovascular risk, chronic inflammation, glucose intolerance, metabolic disorders #Meta...
Anti Tumor Immunity Anti-tumor immunity refers to the body’s natural and therapeutic immune responses that recognize and eliminate cancer cells . It involves both innate and adaptive immune mechanisms, including cytotoxic T lymphocytes , natural killer (NK) cells, dendritic cells, macrophages, and immune signaling molecules such as cytokines and chemokines. These components work together to detect tumor-associated antigens, overcome immune evasion strategies used by cancer cells, and suppress tumor growth and metastasis. Advances in cancer immunology have led to transformative therapies—such as immune checkpoint inhibitors, cancer vaccines, adoptive cell therapies, and monoclonal antibodies—that harness or enhance anti-tumor immunity to improve patient outcomes. Anti-tumor immunity, cancer immunology, immune surveillance, T cell activation, natural killer cells, tumor antigens, immune checkpoints, immunotherapy, tumor microenvironment, immune evasion #AntiTumorImmunity, #Cance...